It simply states that 1/3 of the folks in the study had stable or grew the telomeres during a 10 year period. I find this fantastic, as it certainly allows for an outside influence that can activate the hypothetical cellular TL regulating mechanism, that these folks are proposing.
If these individuals don't live longer and seem morphologically younger, that would undermine the basis for thinking that increasing telomere length in humans would be anti-aging.
That is true, but this study does not provide this data. It also does not show how quickly the telomere length shortened after this increase in length, until the death of a subject. It doesn't provide pictures of the subjects, etc. Now, what is interesting is that If it's true that telomerase focuses on short telomeres over longer telomeres as suggested by the study, it's certainly possible that telomerase may have not worked very much or at all after a certain length was achieved... so...
According to part of the study:
The individual telomere attrition rate was inversely correlated with initial TL at a highly significant level (r = –0.752, P<0.001), indicating that the attrition rate was most pronounced in individuals with long telomeres at baseline.
It would seem that at one point when achieving, or having long telomeres, the attrition rate would be very much increased. We don't have the data for attrition after the later part of the 10 year period, so we don't know if there was rapid attrition after this period of telomere lengthening. I figure activating telomerase, say by activating it through a capsule, may limit the speed of attrition of the longer telomeres.
Now, if you want evidence that telomere is not associated with age at all, this study simply doesn't provide that kind of evidence. What it seems to provide, is a hypothetical TL regulating mechanism, that I find interesting. The other thing is that this study is strictly on blood cells, while other cells were not tested.
What I really found interesting was the talk about Cancer:
The working hypothesis that blood cell TL can indicate a later development of a malignant tumor was not supported in the present study. This hypothesis emanates from data showing altered TL in cases with a variety of malignancies. In urinary bladder, head and neck, lung, and renal cell cancers, shortened blood telomeres have been described at diagnosis, whereas data on breast cancer indicate unchanged or longer telomeres compared to controls [12]–[15]. Since no difference in TL existed between cases and controls, neither ≥9 (sample 1) nor 0–11 (sample 2) years before the appearance of a malignancy, we conclude that blood TL is not a prediagnostic biomarker for malignancy per se.
Cheers
A
Edited by Anthony_Loera, 13 May 2009 - 10:21 PM.